Biological, prognostic, and therapeutic impact of the epigenome in CLL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biological, prognostic, and therapeutic impact of the epigenome in CLL

Published:2023-12 Issue: Volume: Page:
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Maiques-Diaz Alba,Martin-Subero Jose Ignacio^ORCID

Funder

Ministerio de Ciencia e Innovación

Fundació la Marató de TV3

Horizon 2020

HORIZON EUROPE European Research Council

Centro de Investigación Biomédica en Red de Cáncer

European Research Council

Agència de Gestió d'Ajuts Universitaris i de Recerca

Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Hematology

Reference66 articles.

1. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies;Delgado;Haematologica,2020

2. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia;Ahn;Blood,2017

3. Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia;Herling;NatCommun,2018

4. Targeted therapies in CLL: mechanisms of resistance and strategies for management;Woyach;Blood,2015

5. Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL;Kwok;Blood,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP